XBiotech
XBIT
$4.76
Share price
-2.71%
Change (1 day)
-67.80%
Change (1 year)
Categories
XBiotech (XBIT) - Cash on Hand
Cash on Hand as of December 2024 : A$0.28 Billion
According to XBiotech's latest financial reports the company has A$0.28 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
XBiotech - Cash on Hand chart (from 2013 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$0.27 B | -5.44% |
| 2023-12-31 | A$0.29 B | -8.13% |
| 2022-12-31 | A$0.31 B | -2.23% |
| 2021-12-31 | A$0.32 B | 5.89% |
| 2020-12-31 | A$0.30 B | -69.75% |
| 2019-12-31 | A$1.02 B | 4444.13% |
| 2018-12-31 | A$22.46 M | -44.8% |
| 2017-12-31 | A$40.69 M | -14.55% |
| 2016-12-31 | A$47.61 M | -61.9% |
| 2015-12-31 | A$0.12 B | 78.42% |
| 2014-12-31 | A$70.05 M | 762.56% |
| 2013-12-31 | A$8.12 M | 102.53% |
| 2012-12-31 | A$4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | A$66.85 M | -76.66% | 🇺🇸 USA |
 | A$42.22 M | -85.26% | 🇺🇸 USA |
 | A$0.60 B | 112.84% | 🇳🇱 Netherlands |